Nucala (mepolizumab) is a brand-name subcutaneous injection that comes in different forms. Depending on which form you’re prescribed, you or your doctor will administer the injection. Nucala injection ...
Nucala (mepolizumab) and Dupixent (dupilumab) are prescription drugs used to treat chronic rhinosinusitis with nasal polyps, asthma, and COPD. Both drugs come as a liquid solution for injection under ...
Nucala (mepolizumab) is a prescription injection used to treat a type of asthma and other inflammatory conditions. Nucala isn’t known to interact with other drugs, alcohol, or supplements. But certain ...
Learn more about NUCALA (mepolizumab), a targeted biologic treatment approved for five different conditions.
NUCALA is an add-on, prescription maintenance treatment for patients 6 and older with severe eosinophilic asthma. NUCALA is not used to treat sudden breathing problems.
Learn about the possible risks and side effects of using NUCALA (mepolizumab). See Full Safety & Prescribing Information.
Find the answers to frequently asked questions about NUCALA (mepolizumab) and the conditions it treats.
Struggling with COPD symptoms? NUCALA (mepolizumab) is an add-on, prescription treatment for adults with uncontrolled eosinophilic COPD. Not for sudden breathing problems.
Aprende más sobre NUCALA (mepolizumab), una opción de tratamiento con receta. Consulta la Información de Prescripción y Seguridad Completa.
NUCALA is a once-monthly,* add-on, prescription maintenance treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) in adults whose disease is not controlled with nasal corticosteroids. It’s a non-surgical option for treating nasal polyps. *Every 4 weeks.
NUCALA is a prescription medicine for the treatment of adults with eosinophilic granulomatosis with polyangiitis (EGPA). NUCALA was approved for EGPA in December 2017 and is the only biologic for EGPA with 6+ years of patient experience.